Chinese General Practice ›› 2024, Vol. 27 ›› Issue (16): 2033-2038.DOI: 10.12114/j.issn.1007-9572.2023.0084
Special Issue: 心血管最新文章合集
• Review & Perspectives • Previous Articles Next Articles
Received:
2023-08-07
Revised:
2023-10-24
Published:
2024-06-05
Online:
2024-04-08
Contact:
YANG Xinghua
通讯作者:
杨兴华
作者简介:
作者贡献:
倪雪桐负责论文整体写作构思、制定检索策略、收集与整理文献、撰写论文和论文修订;王若羲负责文献搜集与整理;张晶负责文章的修订与质量控制;杨兴华负责论文的修订、文章的质量控制及审校。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0084
[1] | |
[2] |
|
[3] |
|
[4] |
|
[5] |
蔡联英,王文娟,梁运啸,等. 代谢相关脂肪性肝病与代谢综合征相关性的研究进展[J]. 中国临床新医学,2021,14(7):730-734. DOI:10.3969/j.issn.1674-3806.2021.07.22.
|
[6] |
吴婉雯,李晓伟,崔立红. 脂肪肝诊断标准的变更对心血管疾病风险分层管理的价值分析[J]. 解放军医学杂志,2021,46(5):486-491. DOI:10.11855/j.issn.0577-7402.2021.05.10.
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志,2018,34(5):947-957. DOI:10.3969/j.issn.1001-5256.2018.05.007.
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
屠燕,杨婵娟,黄莹,等. 非酒精性脂肪肝与心血管疾病相关性的研究[J]. 自然杂志,2022,44(2):149-154. DOI:10.3969/j.issn.0253-9608.2022.02.008.
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
缪茜. NAFLD及MAFLD患者主要心血管病发病风险及预测研究[D]. 兰州:兰州大学,2022.
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] | |
[47] |
|
[1] | NI Jiachun, CAI Zengjin, HOU Changcheng, JIANG Qiong, KANG Jian, YANG Xiangdong, FAN Wenbin. Hemorrhoidal Disease Classification Methods: Recent Advances and Value Analysis [J]. Chinese General Practice, 2024, 27(20): 2545-2550. |
[2] | HOU Nana, FENG Jinzhang, LIU Suohong, FENG Junfang, XUE Xiaoyan, YIN Na, CHI Gefu. Correlation between Serum Uric Acid/Creatinine Ratio and Metabolism-associated Fatty Liver Disease [J]. Chinese General Practice, 2024, 27(20): 2476-2482. |
[3] | LI Mengye, JIANG Yinong. Recent Advances in Soluble Prorenin Receptor in Multisystem Diseases [J]. Chinese General Practice, 2024, 27(18): 2295-2300. |
[4] | KANG Yinnan, SHI Jiaqi, WANG Junke, LI Bin, LI Chuyi, MA Jun, YU Xiaohui. Advances in the Application of Antibody Drug Conjugate in Gastric Cancer with Low Expression of Human Epidermal Growth Factor Receptor 2 [J]. Chinese General Practice, 2024, 27(18): 2287-2294. |
[5] | MIAO Lipeng, REN Kehao, LI Mengdie, LYU Juncheng. Trend Analysis and Prediction of Cardiovascular Disease Mortality in China from 2009 to 2021 [J]. Chinese General Practice, 2024, 27(18): 2260-2264. |
[6] | LI Jingjing, ZHENG Gaigai, WANG Yu, LIU Yancun, ZHANG Shuangqi, YANG Qiaofang. A Systematic Review of Symptom Assessment Tools for Patients with Heart Failure [J]. Chinese General Practice, 2024, 27(18): 2272-2278. |
[7] | XUE Yanan, OU Minxing, ZHANG Xiujie, MENG Qingxue, LIU Ying. Interpretation of Key Points of 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease [J]. Chinese General Practice, 2024, 27(18): 2173-2178. |
[8] | YANG Xu, YAO Mi. Interpretation of the U.S. Preventive Clinical Services Guidelines Workgroup's Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults without Cardiovascular Disease Risk Factors: Behavioral Counseling Interventions [J]. Chinese General Practice, 2024, 27(17): 2064-2069. |
[9] | XU Ziwei, CHENG Kangyao, GUI Li. A Scoping Review of Research on the Management of Surge Hospitals during a Major Infectious Disease Outbreak [J]. Chinese General Practice, 2024, 27(16): 2039-2044. |
[10] | WANG Fangfang, ZHU Li, XING Jiajia, PANG Rizhao, GOU Xiang, ZHANG Anren. Research Progress on the Changes of Intestinal Barrier and Possible Mechanism after Traumatic Central Nervous System Injury [J]. Chinese General Practice, 2024, 27(14): 1775-1781. |
[11] | CAO Jiacen, ZHANG Hongkun, ZHAO Wen, NAN Yuemin, LI Dongdong. Progress of Heme Oxygenase-1 Mediated Ferroptosis in Non-alcoholic Fatty Liver Disease [J]. Chinese General Practice, 2024, 27(14): 1782-1788. |
[12] | DU Shuqin, QIAN Lifeng, XIONG Lie, SHI Hanqiang, SHI Yanbo. Ferroptosis: a New Target for the Treatment of Depressive Disorder [J]. Chinese General Practice, 2024, 27(12): 1417-1423. |
[13] | RAN Dongsheng, LU Yanyan, XIN Chunling, MA Yingcai. Research Progress on the Correlation of Dyslipidemia with Colorectal Serrated Lesions and Colorectal Cancer [J]. Chinese General Practice, 2024, 27(12): 1424-1430. |
[14] | ZHANG Nawen, HUANG Shaomin, TIAN Limin. Association between Serum Osteocalcin Level and Non-alcoholic Fatty Liver Disease in Adults: a Meta-analysis [J]. Chinese General Practice, 2024, 27(12): 1519-1524. |
[15] | SHI Weili, LI Mingyan, DUAN Hongyan. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Interpretation of the U.S. Preventive Services Task Force Recommendation Statement [J]. Chinese General Practice, 2024, 27(12): 1405-1412. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||